SCHEMBL28487695

SCHEMBL28487695

O=C(CN1CCOCC1)Nc1ncc2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ ALDH1A1 P00352 9/20 0.55
▸ JAK3 P52333 1/20 0.55
▸ KDM4E B2RXH2 5/20 0.54
▸ TSHR P16473 2/20 0.53
▸ GAA P10253 5/20 0.53
▸ MAPT P10636 3/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ HPGD P15428 4/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ GLA P06280 1/20 0.52
▸ MGLL Q99685 1/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20949327 0.80 GSK3B (0.72) JAK3GSK3BDYRK1A
SCHEMBL20948711 0.79 GSK3B (0.58) JAK3TSHRGSK3BDYRK1A
SCHEMBL20950853 0.79 GSK3B (0.58) JAK3MGLLGSK3BDYRK1A
SCHEMBL20950462 0.78 GSK3B (0.72) JAK3GSK3BDYRK1A
SCHEMBL20949724 0.78 DYRK1A (0.72) GSK3BDYRK1A
SCHEMBL20950190 0.78 DYRK1A (0.72) JAK3GSK3BDYRK1A
SCHEMBL20949883 0.77 GSK3B (0.59) JAK3GSK3BDYRK1A
SCHEMBL20947437 0.77 GSK3B (0.72) SMN1; SMN2GSK3BDYRK1A
SCHEMBL20966864 0.77 GSK3B (0.47) JAK3TSHRGSK3BDYRK1A
SCHEMBL20949402 0.77 GSK3B (0.72) GSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111973602-B Application of morpholinyl acetamido quinazoline compound as EGFR (epidermal growth factor receptor) inhibitor 浙江工业大学 2022-02-11 — — CN disclosed
CN-111973602-A Application of morpholinyl acetamido quinazoline compound as EGFR (epidermal growth factor receptor) inhibitor 浙江工业大学 2020-11-24 — — CN disclosed
Send feedback